Respiratory disease diagnostics ProAxsis secures c.£1.8 million investment

LONDON: NetScientific Plc (AIM: NSCI) announced that its portfolio company ProAxsis Limited has successfully closed a c.£1.8 million investment. The investment was led by the Company’s wholly owned venture capital and corporate finance firm, EMV Capital, syndicated from a cohort of private investors. The Investment includes c.£211,000 from new investors, c.£36,000 from the exercise of…